Suppression With Empagliflozin as an Alternative To High-Fat Low-Carbohydrate Diet for Myocardial F-fluorodeoxyglucose Positron Emission Tomography (FDG-PET) Imaging
Clinical trial NCT06350903 · COMPLETED
Trial details
- NCT number
- NCT06350903
- Sponsor
- Matthieu Pelletier-Galarneau, MD MSc
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-01
- Primary completion
- 2024-11-01
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.